bioAffinity Technologies BIAF
NASDAQ BIAF
$3.54 -0.12 (-3.28%)
As of: Oct 21, 2026 · 11:39 AM EDT

bioAffinity Technologies (BIAF) Current Debt (2023 - 2026)

Updated

bioAffinity Technologies (BIAF) reported Current Debt of -$45,375 for FY2025, compared with $191,849 in FY2024.

Analysis

bioAffinity Technologies (BIAF) Current Debt (2023 - 2026) Analysis & Trends

Dating back to FY2022, bioAffinity Technologies' Current Debt record includes 4 years.

  • Five-year annual Current Debt spans a low of -$251,746 in FY2023 and a high of $555,148 in FY2022.
  • According to Business Quant data, Current Debt came in at $191,849 in FY2024, -$251,746 in FY2023 and $555,148 in FY2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Debt (Qtr)
1 HCA Healthcare 102.01 Bn 98.02 Bn - 1.24 Bn
2 Natera 59.82 Bn 55.50 Bn 485.19 Mn -
3 Quest Diagnostics 26.42 Bn 24.55 Bn 1.03 Bn -
4 Labcorp Holdings 26.31 Bn 24.06 Bn 1.11 Bn -150.00 Mn
5 Tenet Healthcare 22.59 Bn 11.60 Bn - -
6 Guardant Health 22.50 Bn 18.57 Bn 219.03 Mn -
7 BrightSpring Health Services 12.93 Bn 11.27 Bn 492.75 Mn -
8 Fresenius Medical Care AG 12.56 Bn 4.52 Bn 1.52 Bn 398.20 Mn
9 Tempus AI 12.24 Bn 9.27 Bn 246.50 Mn -
10 bioAffinity Technologies 1.23 Mn -18.45 Mn - -46,109.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -46,109.00
Mar 31, 2026 -41,339.00
Sep 30, 2025 101,156.00
Jun 30, 2025 -74,024.00
Mar 31, 2025 -38,927.00
Dec 31, 2024 -96,911.00
Sep 30, 2024 261,888.00
Jun 30, 2024 -851.00
Mar 31, 2024 27,723.00
Sep 30, 2023 -42,334.00
Jun 30, 2023 -126,096.00
Mar 31, 2023 -83,316.00
API Access

bioAffinity Technologies Current Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-debt&ticker=BIAF&period=max&api_key=YOUR_API_KEY